| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |